Last checked at 26 Mar 2018 21:56
Reuters Health News Summary
Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Bloomsbury Share News (BMY)
BMY Share
Price
BMY Share
News
BMY Share
Chat
BMY Share
Trades
BMY
Live RNS
BMY Share
Charts
BMY Level 2
Console
BMY Live
Share Price
BMY Broker
Ratings
BMY Directors
Deals
BMY Financial
Diary
BMY
Fundamentals
BMY Short
Positions
BMY
Media
Bloomsbury Information
Share Price Information for Bloomsbury (BMY)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
530.00
Bid:
528.00
Ask:
534.00
Change:
0.00 (0.00%)
Spread:
6.00 (1.136%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
530.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Sunday tips round-up: Bloomsbury Publishing, Reckitt
Sun, 24th Apr 2011 15:21
The archives have an extensive back catalogue of historical documents and photographs. These relate to events such as the Titantic disaster and the Magna Carta, and Bloomsbury will publish new print books, ebooks and iPad apps using material from the archive. Bloomsbury shares were recommended because of its new strategy to "generate value from within" - especially across digital platforms. Indeed, at its update in February, the company said that e-book sales grew eighteen-fold in 2010 from $131,000 (£79,000) to $2.3m. The Telegraph´s Questor team continues to say BUY.Rakesh Kapoor, a company veteran of more than 20 years, will succeed Mr Becht. The outlook for fast-moving consumer goods is strong. Emerging markets are adding millions of new middle-class customers every year and larger players with global brands should be able to capitalise on this. The company tabled a good performance in developing markets in the first quarter, with sales in Asia, Africa, Latin America and eastern Europe more than offsetting weakness in western Europe and North America. (...) Questor downgraded the stance to hold when the (Reckitt) shares were at £32.70 in February. However, these figures have given the detractors pause for thought - especially the like-for-like number - and the shares are once again a buy, says Questor. ab
More News
26 Mar 2018 13:56
Reuters Health News Summary
Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among
Read more26 Mar 2018 13:56
Reuters Health News Summary
Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among
Read more26 Mar 2018 07:23
UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success
ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial
Read more25 Mar 2018 14:15
Israel to launch Big Data health project
By Maayan Lubell JERUSALEM, March 25 (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a to a
Read more20 Mar 2018 07:05
UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer
ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not
Read more19 Mar 2018 17:59
Bloomsbury Publishing Expecting Profitability To Beat Expectations
LONDON (Alliance News) - Bloomsbury Publishing PLC said on Monday it expects its full-year profit and revenue to both be ahead of expectations.For the year ending 28 to
Read more13 Jul 2016 12:55
Bloomsbury Publishing plots expansion into B2B market
(ShareCast News) - Harry Potter publisher Bloomsbury Publishing held a capital markets day for investors and analysts on Wednesday to present plans to enter the business-to-business market, while also confirming first-quarter trading remained in line with full year expectations. Bloomsbury unveiled
Read more12 Jul 2016 15:11
8 Jul 2016 15:00
19 May 2016 12:43
Bloomsbury moves towards digital B2B after strong FY
(ShareCast News) - Bloomsbury, the publisher behind the Harry Potter phenomenon, has turned in an overall strong set of full-year results and launched a 2020 strategy to move into digital B2B publishing. It booked a full-year pretax profit of £10.36m, from a year-earlier profit of £9.60m, with reven
Read more